Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

26.5%

13 terminated/withdrawn out of 49 trials

Success Rate

60.6%

-25.9% vs industry average

Late-Stage Pipeline

24%

12 trials in Phase 3/4

Results Transparency

30%

6 of 20 completed trials have results

Key Signals

2 recruiting6 with results9 terminated4 withdrawn

Enrollment Performance

Analytics

N/A

14(43.8%)

Phase 4

10(31.3%)

Phase 2

3(9.4%)

Phase 3

2(6.3%)

Phase 1

2(6.3%)

Early Phase 1

1(3.1%)

32Total

N/A(14)

Phase 4(10)

Phase 2(3)

Phase 3(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (49)

Showing 20 of 49 trials

NCT03947905Not ApplicableWithdrawn

Virtual and Physical Health Assessments and Treatment Plans

Role: lead

NCT01424345Phase 4Terminated

The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient

Role: lead

NCT07443254Phase 1Recruiting

Prospective IR-led Sedation Feasibility

Role: lead

NCT06764966Phase 2Recruiting

Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis

Role: lead

NCT07040163Early Phase 1Active Not Recruiting

Evaluation of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology

Role: lead

NCT04705480Phase 4Completed

Pregabalin vs. Gabapentin on Reducing Opioid Usage

Role: lead

NCT03289520Phase 3Completed

Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis

Role: collaborator

NCT03699982Not ApplicableTerminated

Resting Energy Expenditure in Patients With Cystic Fibrosis: A Pilot Study

Role: lead

NCT05970354Phase 4Enrolling By Invitation

EMLA Cream as Analgesic for Outpatient Gynecological Procedures

Role: lead

NCT04003012Phase 4Completed

Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures

Role: lead

NCT03494738Unknown

Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum Disorder

Role: lead

NCT03586362Unknown

Vancomycin De-escalation Therapy in Patients With Pneumonia

Role: lead

NCT02924480Not ApplicableCompleted

Intravenous Lidocaine for Cystectomy Procedures

Role: lead

NCT04759859Withdrawn

Neuropsychological Functioning and Cerebral Perfusion Post Carotid Endarterectomy

Role: lead

NCT01916616Not ApplicableCompleted

A Multidisciplinary Approach to Vocal Cord Dysfunction: A Novel Pilot Study

Role: lead

NCT02417168Terminated

Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study

Role: lead

NCT00919464Not ApplicableTerminated

Natural History of Anterior Compartment Pressures of the Thigh Following Femur Fracture

Role: lead

NCT04295694Completed

Effect of Infant Immunization on Procalcitonin Levels - A Pilot Study

Role: lead

NCT00967941Completed

Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis

Role: lead

NCT04279457Phase 4Unknown

Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System

Role: lead